Phase I. Trial Site MŰSZERKÖZPONTOK
Phase I. Trial Site
PROF. DR. CSABA LENGYEL, PH.D., HABIL., TRIAL SITE DIRECTOR

IMG_1260-001

Professor Lengyel serves as the Head of the Clinical Pharmacology Board and a Principal Investigator, with specializations in clinical pharmacology, internal medicine, diabetology, cardiology, and lipidology. He is also a certified hypertension specialist and primary care physician. In addition to these roles, he is the Head of the Department of Internal Medicine and President of the Szent-Györgyi Albert Clinical Center at the University of Szeged.

As a clinical pharmacologist and internal medicine specialist, Professor Lengyel’s expertise is centered on diabetology, cardiology, lipidology, and hypertension management. His extensive research focuses on cardiovascular diseases and diabetes, along with their respective complications. Over the course of his academic career, he has authored more than 650 publications, which have received thousands of independent citations. He actively participates in clinical trials, including Phase I research, and is deeply committed to mentoring young researchers and nurturing the next generation of scientific talent, alongside his teaching responsibilities.

DR. RÓBERT TAKÁCS, DEPUTY TRIAL SITE DIRECTOR

9K2A9020

Dr. Takács is a Chief Clinical Physician and healthcare manager, specializing in internal medicine, endocrinology, clinical pharmacology, diabetology, and the treatment of obesity and hypertension.

Dr. Takács serves as Chief Clinical Physician at the Department of Internal Medicine at the University of Szeged, where he is committed to providing high-quality care to patients with conditions related to internal medicine, endocrinology, and diabetology. As a clinical pharmacologist with expertise in healthcare management, he plays an active role in clinical trials for new drugs, particularly in Phase I research, while also contributing significantly to the organization and advancement of healthcare services. His research focuses on the treatment of diabetes, obesity, and hypertension, as well as modern therapeutic approaches for endocrine diseases. Throughout his academic career, he has authored numerous publications in both Hungarian and international journals and regularly presents his findings at professional conferences.

Email: takacs.robert@med.u-szeged.hu

Specialist in intensive care medicine, specialist in internal medicine, and a resident in clinical pharmacology.

He has many years of clinical experience in intensive care and emergency medicine. As a university lecturer, he is involved in both undergraduate and postgraduate education in critical care, teaching in English and German as well. His scientific work focuses on mechanical organ support and point-of-care ultrasound examinations.

He joined the Phase I clinical trial unit as a clinical pharmacology resident. He is currently also enrolled in the postgraduate Clinical Research Manager (CRM) program at the Faculty of Pharmacy.

DR. ANNAMÁRIA BJELIK FACILITY MANAGER

Bjelik_Annamaria

Biologist with a specialization in molecular biology, holding a PhD in Clinical Medical Sciences. Her scientific research focuses on Alzheimer’s disease. As a university lecturer, she has taught cell biology and neurobiology in both Hungarian and English. She has gained significant experience in the pharmaceutical industry, particularly in sales and patient recruitment. She joined the Phase I clinical trial unit as a facility manager and is responsible for developing a patient recruitment system for clinical research at the university level. She is currently also a student in the postgraduate Clinical Research Manager (CRM) program at the Faculty of Pharmacy.

E-mail: bjelik.annamaria@szte.hu